Peptide mass: 10mg Bacteriostatic water: 2mL Concentration: 10mg 2mL = 5 mg/mL = 5,000 mcg/mL Peptide per unit (100-unit syringe): 5 mg 100 = 0.05 mg/unit = 50 mcg/unit If research protocol calls for 250 mcg per research unit: 250 mcg 50 mcg/unit = 5 units on the syringe Total doses per vial at 250 mcg each: 10,000 mcg 250 mcg = 40 research doses That single 10mg vial, reconstituted with 2mL of bacteriostatic water, provides 40 research doses of 250 mcg each, drawn to the 5-unit mark on a standard insulin syringe
Potential side effects include: Nausea or mild stomach upset Fatigue Headache Gas or changes in bowel movements Low blood sugar (rare) If side effects are prolonged or difficult to tolerate, providers may recommend alternatives such as tirzepatide, which can have a different side effect profile.
FDA-Approved Pill & Injection Wegovy FDA-approved reference Brand-name semaglutide by Novo Nordisk
markets for franchise development
Elizabeth Chen, Endocrinologist & Metabolic Researcher Clinically Observed Results Lose up to 810 lbs of fat in 7 days Visibly flatter stomach & reduced bloating Improved blood pressure, cholesterol, & energy Reduced cravings & improved mood Enhanced metabolic rate & digestion Just one vial (0.7 ml) per day is all it takes
A., & Gooley, J
